Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan;110(1):146-147.
doi: 10.1007/s00392-020-01653-6. Epub 2020 Apr 23.

No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity

Affiliations
Comment

No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity

Gerui Li et al. Clin Res Cardiol. 2021 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declared there is no conflict of interest.

Comment on

References

    1. Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020 doi: 10.1007/s00392-020-01626-9. - DOI - PMC - PubMed
    1. Chen C, Chen C, Yan JT, et al. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48:E008–E008. doi: 10.3760/cma.j.cn112148-20200225-00123. - DOI - PubMed
    1. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020 doi: 10.1001/jamainternmed.2020.0994. - DOI - PMC - PubMed
    1. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020 doi: 10.1016/S2213-2600(20)30116-8. - DOI - PMC - PubMed
    1. Zhang H, Penninger JM, Li Y, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensiv Care Med. 2020 doi: 10.1007/s00134-020-05985-9. - DOI - PMC - PubMed